Skip to content
OpenCapital
Get started

Doximity DOCS Cash & Equivalents

Cash & Equivalents at other companies

Microsoft logo
MicrosoftMSFT
$32.11B+11.4%
Veeva Systems logo
Veeva SystemsVEEV
$1.9B-3.5%
Solventum logo
SolventumSOLV
$561M+5.1%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$888.8M+1,598%
Cardinal Health logo
Cardinal HealthCAH
$3.94B+18.4%
Cencora logo
CencoraCOR
$2.18B+10.0%

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-—
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.74B-60.5%
Enterprise value$3.53B-61.7%
P/E19.1×-23.3×
P/S5.8×-10.8×

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0×0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's cash & equivalents?
Doximity (DOCS) reported cash & equivalents of $219.18M in Q1 2026.
How has Doximity's cash & equivalents changed year-over-year?
Doximity's cash & equivalents increased by 4.6% year-over-year, from $209.61M to $219.18M.
What is the long-term trend for Doximity's cash & equivalents?
Over 5 years (2021 to 2026), Doximity's cash & equivalents has grown at a 27.0% compound annual growth rate (CAGR), from $66.39M to $219.18M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.